» Articles » PMID: 12437088

Discovery of Chemokine Substrates for Matrix Metalloproteinases by Exosite Scanning: a New Tool for Degradomics

Overview
Journal Biol Chem
Specialty Biochemistry
Date 2002 Nov 20
PMID 12437088
Citations 45
Authors
Affiliations
Soon will be listed here.
Abstract

Increasingly it is being recognized that matrix metalloproteinases (MMPs) are important processing enzymes that regulate cellular behaviour and immune cell function by selective proteolysis of cell surface receptors and adhesion molecules, cytokines and growth factors. These functions will likely prove to be as important in vivo as the proposed roles of MMPs in pathological matrix degradation. To screen for new protease substrates we have reported a novel 'exosite scanning' strategy that utilizes protease substrate-binding exosite domains as yeast two-hybrid baits. We discovered that the chemokine monocyte chemoattractant protein-3 (MCP-3) binds the hemopexin C domain of gelatinase A (MMP-2) leading to its efficient cleavage, converting an agonist to a potent receptor antagonist. We have now found that other MMPs cleave MCP-1, MCP-2, MCP-3, MCP-4, SDF-lalpha and SDF-1beta indicating that the intersection between the chemokine and MMP families is broad with important implications for the control of inflammatory and immune processes. Use of engineered substrates with altered exosite binding affinities further revealed the power of exosites in dictating proteolytic specificity - either directing cleavage of non-preferred sites or in other cases virtually eliminating proteolysis of readily accessible scissile bonds. Hence, bioinformatic searches for protease substrates based on scissile bond preference will only reveal a subset of substrates unless the influence of exosites is considered.

Citing Articles

GDF11 prevents the formation of thoracic aortic dissection in mice: Promotion of contractile transition of aortic SMCs.

Ren K, Li B, Liu Z, Xia L, Zhai M, Wei X J Cell Mol Med. 2021; 25(10):4623-4636.

PMID: 33764670 PMC: 8107100. DOI: 10.1111/jcmm.16312.


Role of Matrix Metalloproteinases in Angiogenesis and Its Implications in Asthma.

Bajbouj K, Ramakrishnan R, Hamid Q J Immunol Res. 2021; 2021:6645072.

PMID: 33628848 PMC: 7896871. DOI: 10.1155/2021/6645072.


Levels of Selected Matrix Metalloproteinases-MMP-1, MMP-2 and Fibronectin in the Saliva of Patients Planned for Endodontic Treatment or Surgical Extraction.

Matuszczak E, Cwalina I, Tylicka M, Wawrzyn K, Nowosielska M, Sankiewicz A J Clin Med. 2020; 9(12).

PMID: 33297580 PMC: 7762352. DOI: 10.3390/jcm9123971.


Molecular Interactions Stabilizing the Promatrix Metalloprotease-9·Serglycin Heteromer.

Dawadi R, Malla N, Hegge B, Wushur I, Berg E, Svineng G Int J Mol Sci. 2020; 21(12).

PMID: 32545641 PMC: 7352350. DOI: 10.3390/ijms21124205.


Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.

Sanchez J, Lane J, Canals M, Stone M Int J Mol Sci. 2019; 20(10).

PMID: 31096719 PMC: 6566870. DOI: 10.3390/ijms20102417.